Abstract 5675
Background
Chromatin remodeling gene PBRM1 is frequently altered somatically in epithelioid sarcomas and clear cell renal cell carcinomas, but its germline mutation had been reported only once, in a pedigree with familial clear cell renal cell carcinoma (Benusiglio et al., 2015). We present another evidence of a cancer caused by PBRM1 germline mutation in a family with two young sibs, one of whom deceased of round cell soft tissue sarcoma 13 years old.
Methods
For search of mutations we used next generation sequencing (NGS) on Ion S5 platform. For verification of mutations identified by NGS, for mutation segregation analysis and for evaluation of allelic expression expression we used DNA and cDNA Sanger sequencing.
Results
Exome sequencing of cancer related genes identified a heterozygous germline genetic variant p.F1026L (c.3078C>G) in PBRM1 in the leucocyte DNA of the living sibling. This variant is absent from databases and bioinformatic predictors provide ambiguous estimates as to its pathogenicity. Search for this genetic variant in other family members showed that it is also being carried by the father and the older brother of the proband. Sanger sequencing of this variant in the archived tumor material of the deceased revealed its presence in the heterozygous state indicating no signs of allelic imbalance as an inactivation event that would have been consistent with Knudson’s two-hit model. Yet, further examination of allelic expression in tumor revealed loss of expression of the normal allele suggesting functional loss of heterozygosity in favor of the mutant one.
Conclusions
Our finding of functional two-hit inactivation of PBRM1 in the tumour supports its role as a tumour suppressor gene. Moreover, we present a second description of PBRM1 pathogenic germline mutation, and the first to be presumably causative for a soft tissue sarcoma. Absence of any tumours in other PBRM1 mutation carriers in the family described here provides the evidence of low penetrance of this mutation.
Clinical trial identification
Legal entity responsible for the study
Research Centre for Medical Genetics, Moscow.
Funding
State assignment of FASO Russia.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
5877 - TCR beta chain convergence defines the tumor infiltrating T cell repertoire of melanoma and non-small cell lung carcinoma.
Presenter: Timothy Looney
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
3212 - PI3K inhibition and modulation of immune and tumor microenvironment markers by copanlisib in patients with non-Hodgkin's lymphoma or advanced solid tumors
Presenter: Ahmad Awada
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
3574 - Pan-squamous genomic profiling stratified by anatomic tumor site and viral association
Presenter: Meagan Montesion
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4113 - Toward the Standardization of Bioinformatics Methods for the Accurate Assessment of Tumor Mutational Burden (TMB)
Presenter: Han Chang
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4468 - Prediction of primary resistance to anti-PD1 therapy (APD1) in 2nd line NSCLC
Presenter: Egbert Smit
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4570 - Immunomodulatory germline variation impacts the development of multiple primary melanoma (MPM).
Presenter: Robert Ferguson
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1169 - Leukocyte telomere length and recurrence risk after EGFR-TKIs therapy in patients with advanced lung adenocarcinoma
Presenter: Ming Yang
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
1707 - Gene embedding: a novel machine learning approach to identify gene candidates related to immunotherapy responsiveness
Presenter: Chi Tung Choy
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
2123 - Common and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials
Presenter: Ayman Madi
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5671 - The landscape of NTRK fusions in Chinese solid tumor patients
Presenter: Qi Ling
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract